La nefritis lúpica (NL) es un tipo de glomerulonefritis que se desarrolla como consecuencia del
lupus eritematoso sistémico (LES), una enfermedad autoinmune sistémica de presentación
clínica variable (1, 2). La NL se clasifica histológicamente en seis clases(I-VI) (3), las cuales poseen
diferentes ...
Chung, Sharon;
Gorelik, Mark;
Langford, Carol;
Maz, Mehrdad;
Abril, Andy;
Guyatt, Gordon;
Archer, Amy;
Conn, Doyt;
Full, Kathy;
Grayson, Peter;
Ibarra, Maria;
Mustafa, Reem.
To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic...
Maz, Mehrdad;
Chung, Sharon;
Abril, Andy;
Langford, Carol;
Gorelik, Mark;
Guyatt, Gordon;
Archer, Amy;
Conn, Doyt;
Full, Kathy;
Grayson, Peter;
Ibarra, Maria;
Imundo, Lisa;
Mustafa, Reem.
To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, c...
Fraenkel, Liana;
Bathon, Joan;
England, Bryant;
St Clair, William;
Arayssi, Thurayya;
Carandang, Kristine;
Deane, Kevin;
Genovese, Mark;
Huston, Kent;
Kerr, Gail;
Akl, Elie;
Turner, Amy.
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluat...
This guideline covers the management of Crohn's disease in children, young people and adults. It
aims to reduce people's symptoms and maintain or improve their quality of life....
Esta Guía Rápida forma parte de la Guía de Práctica Clínica para el Manejo de Pacientes con Artritis Reumatoide, elaborada por la Sociedad Española de Reumatología con la ayuda de un equipo multidisciplinar de profesionales. Constituye una ayuda para la toma de decisiones en la atención sanitaria...
Goodman, SM;
Springer, B;
Guyatt, G;
Abdel, MP;
Dasa, V;
George, M;
Gewurz-Singer, O;
Giles, JT;
Johnson, B;
Lee, S;
Mandl, LA;
Mont, MA;
Sculco, P;
Sporer, S;
Stryker, L;
Turgunbaev, M;
Brause, B;
Chen, AF;
Gililland, J;
Goodman, M;
Hurley-Rosenblatt, A;
Kirou, K;
Losina, E;
MacKenzie, R;
Michaud, K;
Mikuls, T;
Russell, L;
Sah, A;
Miller, AS;
Singh, JA;
Yates, A.
OBJECTIVE: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) includin...
Ward, M. M;
Deodhar, A;
Akl, E. A;
Lui, A;
Ermann, J;
Gensler, L. S;
Smith, J. A;
Borenstein, D;
Hiratzka, J;
Weiss, P. F;
Inman, R. D;
Majithia, V;
Haroon, N;
Maksymowych, W. P;
Joyce, J;
Clark, B. M;
Colbert, R. A;
Figgie, M. P;
Hallegua, D. S;
Prete, P. E;
Rosenbaum, J. T;
Stebulis, J. A;
Bosch, F van den;
Yu, D. T;
Miller, A. S;
Reveille, J. D;
Caplan, L.
OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
Espondilitis Anquilosante/tratamiento farmacológico,
Espondiloartritis/tratamiento farmacológico,
Antiinflamatorios no Esteroideos/uso terapéutico,
Antirreumáticos/uso terapéutico,
Glucocorticoides/uso terapéutico,
Factor de Necrosis Tumoral alfa/uso terapéutico,
Infliximab/uso terapéutico,
Adalimumab/uso terapéutico,
Etanercept/uso terapéutico,
Modalidades de Fisioterapia,
Espondilitis Anquilosante/terapia
Singh, JA;
Saag, KG;
Bridges Jr, SL;
Akl, EA;
Bannuru, RR;
Sullivan, MC;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, RH;
Curtis, JR;
Furst, DE;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, EL;
Schousboe, JT;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, EW;
Tindall, E;
Miller, AS;
McAlindon, T.
OBJECTIVE:
To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).
METHODS:
We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eva...
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
